Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05344560 · ClinicalTrials.gov registry record · NA
Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT05344560 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 126 participants.
The verdict
NCT05344560, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..
Interventions
- DEVICE soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore
- DEVICE ACUVUE OASYS 1-Day for Astigmatism
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2022-05-09 |
| Est. Completion | 2022-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05344560
The ClinicalTrials.gov registry entry for NCT05344560 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore is the first listed.
NCT05344560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05344560 about?
NCT05344560 is a clinical study titled "Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light". This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..
What is the current status of trial NCT05344560?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2022-05-09. Estimated completion is 2022-08-09.
What interventions are being tested in trial NCT05344560?
The interventions under investigation include: soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore (DEVICE), ACUVUE OASYS 1-Day for Astigmatism (DEVICE).
Who is sponsoring clinical trial NCT05344560?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.